This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fusion Antibodies Limited. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Declan Doherty: Innovator in Cancer Treatment
Introduction
Declan Doherty is a notable inventor based in Belfast, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development of antibody molecules.
Latest Patents
Declan holds a patent for "Anti-AREG/HB-EGF antibodies and treatment." This patent describes cross-specific antibody molecules that exhibit binding specificity for both AREG and HB-EGF. These antibody molecules have potential applications in the treatment of cancer and diseases associated with angiogenesis. He has 1 patent to his name.
Career Highlights
Declan is associated with Fusion Antibodies Limited, where he applies his expertise in developing therapeutic solutions. His work focuses on advancing the understanding and treatment of complex diseases.
Collaborations
Declan collaborates with talented individuals such as Jill Caswell and Shane Olwill, contributing to a dynamic research environment.
Conclusion
Declan Doherty's innovative work in developing antibody treatments showcases his commitment to improving cancer therapies. His contributions are paving the way for advancements in medical science.